[1] Kommu, S., Whitfield, P., (2025), Semaglutide
The lowest representation of white participants was in trials sponsored by the National Institute of Allergy and Infectious Diseases and the National Institute of Child Health and Human Development (both consistently less than 50 percent)
As well as efficacy for weight loss, glycemic control and other phenotypes, we are also examining the safety and tolerability of these drugs
Novel anti-obesity medications, including Tirzepatide and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), have demonstrated effective weight reduction and glycemic control 11,12,13
Both medications are not right for people with a personal or family history of a rare thyroid cancer called medullary thyroid carcinoma (MTC), or a hereditary condition called MEN2 (multiple endocrine neoplasia type 2), which causes tumors to grow in hormone-producing glands
Furthermore, healthcare givers need to guide and organize necessary care for patients who need renal replacement therapy (a treatment for advanced kidney failure) to ensure they get healthier